SALONPAS ANALGESIC PATCH MONOGRAPH STATUS REQUIRES "SOME EVIDENCE"
This article was originally published in The Tan Sheet
Executive Summary
SALONPAS ANALGESIC PATCH MONOGRAPH STATUS REQUIRES "SOME EVIDENCE" that the safety and efficacy of the active ingredients are not adversely affecting the product's patch delivery form, FDA Monograph Review Staff Deputy Director Gerald Rachanow said Oct. 4 at an "OTC feedback" meeting in Rockville, Md. "You have to have at least some evidence that you do not think that the patch is inhibiting the drug's effect," Rachanow advised Hisamitsu company representatives.